These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35455310)

  • 1. Low-Temperature Multiple Micro-Dispensing on Microneedles for Accurate Transcutaneous Smallpox Vaccination.
    Yim SG; Hwang YH; An S; Seong KY; Kim SY; Kim S; Lee H; Lee KO; Kim MY; Kim D; Kim YJ; Yang SY
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live Vaccinia Virus-Coated Microneedle Array Patches for Smallpox Vaccination and Stockpiling.
    Choi IJ; Cha HR; Hwang SJ; Baek SK; Lee JM; Choi SO
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33546332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus.
    Xiao Y; Zeng Y; Schante C; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN
    Vaccine; 2020 Aug; 38(38):6007-6018. PubMed ID: 32741672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery.
    Oh YJ; Cha HR; Hwang SJ; Kim DS; Choi YJ; Kim YS; Shin YR; Nguyen TT; Choi SO; Lee JM; Park JH
    Drug Deliv Transl Res; 2021 Aug; 11(4):1390-1400. PubMed ID: 33759112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coated microneedle arrays for transcutaneous delivery of live virus vaccines.
    Vrdoljak A; McGrath MG; Carey JB; Draper SJ; Hill AV; O'Mahony C; Crean AM; Moore AC
    J Control Release; 2012 Apr; 159(1):34-42. PubMed ID: 22245683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
    Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
    Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
    Ameri M; Ao Y; Lewis H
    AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
    Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
    Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines.
    Meseda CA; Atukorale V; Kuhn J; Schmeisser F; Weir JP
    PLoS One; 2016; 11(2):e0149364. PubMed ID: 26895072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedle-based intradermal delivery of stabilized dengue virus.
    Turvey ME; Uppu DSSM; Mohamed Sharif AR; Bidet K; Alonso S; Ooi EE; Hammond PT
    Bioeng Transl Med; 2019 May; 4(2):e10127. PubMed ID: 31249877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.
    Moon S; Wang Y; Edens C; Gentsch JR; Prausnitz MR; Jiang B
    Vaccine; 2013 Jul; 31(34):3396-402. PubMed ID: 23174199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles vaccination using a microneedle patch.
    Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
    Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
    Kommareddy S; Baudner BC; Bonificio A; Gallorini S; Palladino G; Determan AS; Dohmeier DM; Kroells KD; Sternjohn JR; Singh M; Dormitzer PR; Hansen KJ; O'Hagan DT
    Vaccine; 2013 Jul; 31(34):3435-41. PubMed ID: 23398932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.